tiprankstipranks
Trending News
More News >

Fosun Pharma Enhances Governance with New Remuneration Committee

Story Highlights
  • Fosun Pharma establishes a committee to manage director and senior management remuneration.
  • The committee aims to improve governance and align management incentives with performance.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Fosun Pharma Enhances Governance with New Remuneration Committee

Don’t Miss TipRanks’ Half-Year Sale

An update from Shanghai Fosun Pharmaceutical (Group) Co ( (HK:2196) ) is now available.

Shanghai Fosun Pharmaceutical has established a Remuneration and Appraisal Committee under its board of directors to enhance its appraisal and remuneration management system for directors and senior management. This committee is responsible for setting appraisal standards, formulating remuneration policies, and making recommendations to the board, aiming to improve corporate governance and align management incentives with company performance. The committee’s establishment is expected to strengthen Fosun Pharma’s governance structure and potentially improve its competitive positioning by ensuring transparent and fair remuneration practices.

The most recent analyst rating on (HK:2196) stock is a Hold with a HK$17.20 price target. To see the full list of analyst forecasts on Shanghai Fosun Pharmaceutical (Group) Co stock, see the HK:2196 Stock Forecast page.

More about Shanghai Fosun Pharmaceutical (Group) Co

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a joint stock limited company incorporated in China, operating in the pharmaceutical industry. The company focuses on the development, manufacture, and sale of pharmaceutical products, medical devices, and healthcare services, with a significant presence in both domestic and international markets.

Average Trading Volume: 7,025,116

Technical Sentiment Signal: Buy

Current Market Cap: HK$65.06B

See more insights into 2196 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1